Table 1.
Patient demographics and baseline characteristics
| Characteristics | n = 30 |
|---|---|
| Median age, years | 56.5 (35–73) |
| Gender, n(%) | |
| male | 18 (60.00%) |
| female | 12 (40.00%) |
| Eastern Cooperative Oncology Group performance status, n (%) | |
| 0 | 2 (6.67%) |
| 1 | 27 (90.00%) |
| 2 | 1 (3.33%) |
| Cholangiocarcinoma location, n(%) | |
| Intrahepatic cholangiocarcinoma | 28 (93.33%) |
| Extrahepatic cholangiocarcinoma | 2 (6.67%) |
| Pathological type, n(%) | |
| Adenocarcinoma | 27 (90.00%) |
| Squamous cell carcinoma | 1 (3.33%) |
| Others | 2 (6.67%) |
| Clinical stage, n(%) | |
| II | 2 (6.67%) |
| IIIB | 4 (13.33%) |
| IVB | 24 (80.00%) |
| Metastasis, n(%) | |
| Yes | 25 (83.33%) |
| Metastatic site, n(%) | |
| Lymphonodus | 17 (56.67%) |
| Bone | 7 (23.33%) |
| Peritoneum | 4 (13.33%) |
| Liver | 3 (10.00%) |
| Lung | 3 (10.00%) |
| Adrenal gland | 1 (3.33%) |
| pelvic cavity | 1(3.33%) |
| Microsatellite stability status, n(%) | |
| microsatellite stable | 30 (100%) |